MAPT and Alzheimer disease: Given that DAPK1 is a potential risk gene for late-onset AD, and its expression is elevated in the brains of AD patients, our data from human AD brain samples reinforce the clinical importance of DAPK1-SENP1-mediated tau SUMOylation in the pathogenesis of AD-related tau pathology.